Elio
Elio provides an AI-powered eco-design co-pilot for the pharmaceutical industry, targeting R&D scientists, process engineers, and product managers. It offers sustainability decision support by calculating impact weighting for materials and production energy, enabling companies to make informed eco-design choices without waiting for perfect data. Elio emphasizes close collaboration with the pharma industry and has initiated the Pharma Eco-design Consortium to address data access management issues and accelerate pre-competitive eco-design solutions. Their approach focuses on practical application and timely decision-making to meet sustainability targets.
Elio
Elio provides an AI-powered eco-design co-pilot for the pharmaceutical industry, targeting R&D scientists, process engineers, and product managers. It offers sustainability decision support by calculating impact weighting for materials and production energy, enabling companies to make informed eco-design choices without waiting for perfect data. Elio emphasizes close collaboration with the pharma industry and has initiated the Pharma Eco-design Consortium to address data access management issues and accelerate pre-competitive eco-design solutions. Their approach focuses on practical application and timely decision-making to meet sustainability targets.
TL;DR
What they do: AI-powered eco-design co-pilot for the pharmaceutical industry
Founded: 2021
Stage / funding: Pre-Seed (most recent round Feb 13, 2025)
Employees: 6
Company Overview
Problem Domain
Sustainability and eco-design decision support for pharmaceutical R&D and production
Founded
2021
Industry
Biotechnology
Tech Stack
Funding Track Record
Most recent round reported on Feb 13, 2025
Investor Signal
“Ananda Impact Ventures, Cerulean Ventures, Stefan Oschmann, and a group of other investors participated in funding”